Posterior reversible encephalopathy syndrome (PRES) is associated with seizures, visual disturbances, headache, and altered mental status. Given its presentation, the diagnosis can be mistaken for other severe conditions. Palliative medicine consultants should be aware of PRES and be prepared to counsel families on the treatment and prognosis of this syndrome.
KishfyLCasasolaMBanankhahP, et al.Posterior reversible encephalopathy syndrome (PRES) as a neurological association in severe COVID-19. J Neurol Sci. 2020;414:116943.
2.
StaykovDSchwabS. Posterior reversible encephalopathy syndrome. J Intensive Care Med. 2012;27(1):11–24.
3.
CariddiLPDamavandiPTCarimatiF, et al.Reversible encephalopathy syndrome (PRES) in a COVID-19 patient. J Neurol. 2020;267(11):3157–3160.
4.
HincheyJChavesCAppignaniB, et al.A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334(8):494–500.
ShankarJBanfieldJ.Posterior reversible encephalopathy syndrome: a review. Can Assoc Radiol J. 2017;68(2):147–153.
7.
BartynskiWS. Posterior reversible encephalopathy syndrome, part 2: Controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol. 2008;29(6):1043–1049.
8.
McKinneyAMShortJTruwitCL, et al.Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol. 2007;189(4):904–912.
9.
HindujaA. Posterior reversible encephalopathy syndrome: clinical features and outcome. Front Neurol. 2020;11:71.
10.
ParikhNSSchweitzerADYoungRJ, et al.Corticosteroid therapy and severity of vasogenic edema in posterior reversible encephalopathy syndrome. J Neurol Sci. 2017;380:11–15.
11.
FugateJEClaassenDOCloftHJKallmesDFKozakOSRabinsteinAA. Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc. 2010;85(5):427–432.
12.
LargeauBBoelsDVictorri-VigneauCCohenCGandonnièreCSEhrmannS. Posterior reversible encephalopathy syndrome in clinical toxicology: a systematic review of published case reports. Front Neurol. 2020;10:1420.
13.
TetsukaSOgawaT.Posterior reversible encephalopathy syndrome: a review with emphasis on neuroimaging characteristics. J Neurol Sci. 2019;404:72–79.
14.
BartynskiWS. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol. 2008;29(6):1036–1042.
15.
SchweitzerADParikhNSAskinG, et al.Imaging characteristics associated with clinical outcomes in posterior reversible encephalopathy syndrome. Neuroradiology. 2017;59(4):379–386.
16.
BradyEParikhNSNaviBBGuptaASchweitzerAD. The imaging spectrum of posterior reversible encephalopathy syndrome: a pictorial review. Clin Imaging. 2018;47:80–89.
17.
DharRDaceyRHumanTZipfelG. Unilateral posterior reversible encephalopathy syndrome with hypertensive therapy of contralateral vasospasm: case report. Neurosurgery. 2011;69(5):E1176–E1181.
18.
YamagamiKMaedaYIiharaK.Variant type of posterior reversible encephalopathy syndrome associated with deep brain hemorrhage: case report and review of the literature. World Neurosurg. 2020;134:176–181.
YachouYEl IdrissiABelapasovVBenaliSA. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients. Neurol Sci. 2020;41(10):2657–2669.
21.
FranceschiAMAhmedOGilibertoLCastilloM. Hemorrhagic posterior reversible encephalopathy syndrome as a manifestation of COVID-19 infection. AJNR Am J Neuroradiol. 2020;41(7):1173–1176.
22.
RoggJBakerATungG.Posterior Reversible Encephalopathy Syndrome (PRES): another imaging manifestation of COVID-19. Interdiscip Neurosurg. 2020;22:100808.
AnandPLauKHVChungDY, et al.Posterior reversible encephalopathy syndrome in patients with coronavirus disease 2019: two cases and a review of the literature. J Stroke Cerebrovasc Dis. 2020;29(11):105212.
25.
AgarwalAKapurGAltinokD.Childhood posterior reversible encephalopathy syndrome: magnetic resonance imaging findings with emphasis on increased leptomeningeal FLAIR signal. Neuroradiol J. 2015;28(6):638–643.
26.
ParaudaSCGaoVGewirtzAN, et al.Posterior reversible encephalopathy syndrome in patients with COVID-19. J Neurol Sci. 2020;416:117019.
HindujaAHabetzKRainaSRamakrishnaiahRFitzgeraldRT. Predictors of poor outcome in patients with posterior reversible encephalopathy syndrome. Int J Neurosci. 2017;127(2):135–144.
29.
PostmaIRSlagerSKremerHPde GrootJCZeemanGG. Long-term consequences of the posterior reversible encephalopathy syndrome in eclampsia and preeclampsia: a review of the obstetric and nonobstetric literature. Obstet Gynecol Surv. 2014;69(5):287–300.
30.
FugateJERabinsteinAA. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. [Published correction appears in Lancet Neurol. 2015 Sep;14(9):874]. Lancet Neurol. 2015;14(9):914–925.
31.
SundararajanVHendersonTPerryCMuggivanAQuanHGhaliWA. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol. 2004;57(12):1288–1294.
